Literature DB >> 2445677

Kinetic aspects of red blood cell sodium transport systems in essential hypertension.

R P Garay1.   

Abstract

A kinetic study of the interaction of internal sodium with four different erythrocyte sodium transport pathways (ouabain-sensitive Na+-K+ pump, bumetanide-sensitive Na+-K+ cotransport system, Na+-Li+ countertransport, and Na+leak) has facilitated the distinction of the following subgroups of patients with essential hypertension: 1) Leak (+), exhibiting increased passive sodium permeability; 2) Co (-), showing low apparent affinity of the Na+-K+ cotransport system for internal sodium; 3) Counter (+), characterized by increased maximal rates of Na+-Li+ countertransport; and 4) Pump (-), characterized by an abnormally low apparent affinity of the Na+-K+ pump for internal sodium. We present here a new and simple sodium-loading method that allows a simultaneous kinetic study of the above abnormalities. The use of this kinetic assay may improve estimation of the frequencies, clinical features, and other properties of each subgroup of hypertensive patients in different populations.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2445677     DOI: 10.1161/01.hyp.10.5_pt_2.i11

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  3 in total

1.  Abnormal erythrocyte sodium leak in a subset of essential hypertensive patients.

Authors:  A De la Sierra; A Coca; M T Aguilera; A Urbano Márquez
Journal:  Klin Wochenschr       Date:  1989-01-04

Review 2.  Typology of Na+ transport abnormalities in erythrocytes from essential hypertensive patients. A first step towards the diagnosis and specific treatment of different forms of primary hypertension.

Authors:  R Garay
Journal:  Cardiovasc Drugs Ther       Date:  1990-03       Impact factor: 3.727

3.  Primate response to angiotensin infusion and high sodium intake differ by sodium lithium countertransport phenotype.

Authors:  Kimberly D Spradling-Reeves; Robert E Shade; Joseph R Haywood; Laura A Cox
Journal:  J Am Soc Hypertens       Date:  2017-02-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.